FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2163557163> ?p ?o ?g. }

• W2163557163 endingPage "1015" @default.
• W2163557163 startingPage "1009" @default.
• W2163557163 abstract "Five models are proposed to describe the relations among statins, pleiotropic effects, low-density lipoprotein (LDL) cholesterol lowering, and cardiovascular risk reduction. On the basis of the evidence available, the pleiotropic effects of statins do not appear to reduce cardiovascular risk more than would be predicted from LDL cholesterol lowering alone, which suggests that model 1 is not a valid model. Although most attention has focused on models 2 through 4, most data to date support model 3 for describing the relation between statins, inflammation, and cardiovascular risk. Stronger consideration should also be given to model 5, in which pleiotropic effects are the result of cardiovascular risk reduction in and of itself. It may be that other models are operative for nonatherosclerotic inflammatory disorders. However, beneficial effects of statins on rheumatologic or other noncardiovascular may still be due to effects of cholesterol reduction on the immune system, as in model 3. More high-quality research is needed to determine the role of statin pleiotropic effects in cardiovascular risk reduction. Well-designed animal studies can help elucidate potential mechanisms, which will then require confirmation in human studies with cardiovascular event outcomes. Substudies of cardiovascular end point trials and mechanistic studies should be methodologically sound and designed to test specific models. To sort out the independence of pleiotropic effects from LDL cholesterol lowering, studies will need to achieve similar LDL cholesterol reductions in each treatment group. It may be that the biologic impact of a specific pleiotropic effect is mediated by >1 model. Ultimately, once a predominant model has been identified for a given pleiotropic effect, long-term studies would be needed to evaluate the relative contributions of various pleiotropic effects to cardiovascular risk reduction. These findings may reveal new targets for the development of new agents that will prove effective for reducing cardiovascular events when added to LDL cholesterol lowering. To date, little evidence supports consideration of statin pleiotropic effects in clinical decision making. In conclusion, LDL cholesterol is currently the only reliable marker for statin effects on cardiovascular risk reduction. The focus should remain on closing the treatment gap and improving adherence to therapies directed at lowering LDL cholesterol and non-high-density lipoprotein cholesterol to reduce the burden of cardiovascular disease." @default.
• W2163557163 created "2016-06-24" @default.
• W2163557163 creator A5089418361 @default.
• W2163557163 date "2008-04-01" @default.
• W2163557163 modified "2023-10-02" @default.
• W2163557163 title "Models for Describing Relations Among the Various Statin Drugs, Low-Density Lipoprotein Cholesterol Lowering, Pleiotropic Effects, and Cardiovascular Risk††Conflicts of interest: In the past 2 years, Dr. Robinson has received grants from Abbott Laboratories, Abbott Park, Illinois, Astra-Zeneca, Wilmington, Delaware, Bristol-Myers Squibb, Princeton, New Jersey, GlaxoSmithKline, Pittsburgh, Pennsylvania, Hoffman La Roche, Basel, Switzerland, Merck & Company, West Point, Pennsylvania, Pfizer, …" @default.
• W2163557163 cites W1458263521 @default.
• W2163557163 cites W1970674830 @default.
• W2163557163 cites W1972987374 @default.
• W2163557163 cites W1973355122 @default.
• W2163557163 cites W1974327064 @default.
• W2163557163 cites W1976676071 @default.
• W2163557163 cites W1977099568 @default.
• W2163557163 cites W1998391689 @default.
• W2163557163 cites W1999597525 @default.
• W2163557163 cites W2002240714 @default.
• W2163557163 cites W2007954685 @default.
• W2163557163 cites W2016120796 @default.
• W2163557163 cites W2024940226 @default.
• W2163557163 cites W2030743328 @default.
• W2163557163 cites W2033606744 @default.
• W2163557163 cites W2037903557 @default.
• W2163557163 cites W2040462758 @default.
• W2163557163 cites W2043932794 @default.
• W2163557163 cites W2044686773 @default.
• W2163557163 cites W2048995956 @default.
• W2163557163 cites W2058769762 @default.
• W2163557163 cites W2068898353 @default.
• W2163557163 cites W2072308694 @default.
• W2163557163 cites W2074996264 @default.
• W2163557163 cites W2081203120 @default.
• W2163557163 cites W2092316845 @default.
• W2163557163 cites W2093757045 @default.
• W2163557163 cites W2095198102 @default.
• W2163557163 cites W2098885552 @default.
• W2163557163 cites W2102899779 @default.
• W2163557163 cites W2103918731 @default.
• W2163557163 cites W2106343349 @default.
• W2163557163 cites W2107014894 @default.
• W2163557163 cites W2118154631 @default.
• W2163557163 cites W2118209704 @default.
• W2163557163 cites W2121781342 @default.
• W2163557163 cites W2123002906 @default.
• W2163557163 cites W2126090002 @default.
• W2163557163 cites W2126678006 @default.
• W2163557163 cites W2131137214 @default.
• W2163557163 cites W2133685977 @default.
• W2163557163 cites W2142283630 @default.
• W2163557163 cites W2153921323 @default.
• W2163557163 cites W2154863934 @default.
• W2163557163 cites W2163914595 @default.
• W2163557163 cites W2164431067 @default.
• W2163557163 cites W2168628873 @default.
• W2163557163 cites W2247997571 @default.
• W2163557163 cites W4294383028 @default.
• W2163557163 cites W57851565 @default.
• W2163557163 doi "https://doi.org/10.1016/j.amjcard.2007.11.060" @default.
• W2163557163 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18359323" @default.
• W2163557163 hasPublicationYear "2008" @default.
• W2163557163 type Work @default.
• W2163557163 sameAs 2163557163 @default.
• W2163557163 citedByCount "35" @default.
• W2163557163 countsByYear W21635571632012 @default.
• W2163557163 countsByYear W21635571632013 @default.
• W2163557163 countsByYear W21635571632014 @default.
• W2163557163 countsByYear W21635571632015 @default.
• W2163557163 countsByYear W21635571632016 @default.
• W2163557163 countsByYear W21635571632018 @default.
• W2163557163 countsByYear W21635571632019 @default.
• W2163557163 countsByYear W21635571632021 @default.
• W2163557163 countsByYear W21635571632022 @default.
• W2163557163 crossrefType "journal-article" @default.
• W2163557163 hasAuthorship W2163557163A5089418361 @default.
• W2163557163 hasConcept C126322002 @default.
• W2163557163 hasConcept C164705383 @default.
• W2163557163 hasConcept C2776839432 @default.
• W2163557163 hasConcept C2776914184 @default.
• W2163557163 hasConcept C2778163477 @default.
• W2163557163 hasConcept C2779620165 @default.
• W2163557163 hasConcept C2780072125 @default.
• W2163557163 hasConcept C3019882007 @default.
• W2163557163 hasConcept C60644358 @default.
• W2163557163 hasConcept C71924100 @default.
• W2163557163 hasConcept C86803240 @default.
• W2163557163 hasConceptScore W2163557163C126322002 @default.
• W2163557163 hasConceptScore W2163557163C164705383 @default.
• W2163557163 hasConceptScore W2163557163C2776839432 @default.
• W2163557163 hasConceptScore W2163557163C2776914184 @default.
• W2163557163 hasConceptScore W2163557163C2778163477 @default.
• W2163557163 hasConceptScore W2163557163C2779620165 @default.
• W2163557163 hasConceptScore W2163557163C2780072125 @default.
• W2163557163 hasConceptScore W2163557163C3019882007 @default.
• W2163557163 hasConceptScore W2163557163C60644358 @default.
• W2163557163 hasConceptScore W2163557163C71924100 @default.
• W2163557163 hasConceptScore W2163557163C86803240 @default.
• W2163557163 hasIssue "7" @default.
• W2163557163 hasLocation W21635571631 @default.
• W2163557163 hasLocation W21635571632 @default.

• next